Embryo-cell vote spotlights MEPs’ ethics

April 25, 2007

MEPs are divided over EU rules on new types of treatment for diseases such as cancer or Alzheimer’s, with conservative deputies calling for safeguards against medicines developed through embryonic stem cell research, a practice that is illegal in some countries. (EUobserver.com)